Comparing Rezum and Urolift
Recruiting · NCT06820606 · Interventional (participants receive a specific treatment)
View the official record on ClinicalTrials.gov →Interventions studied
RezumUroLift
What this trial is about
This is a randomized controlled trial using a non-inferiority design with the subjects randomized 1:1 to either water vapour thermal treatment (REZUM) arm or prostatic urethral lift (UroLift) arm.
Who can take part
Age range
50 Years and older
Sex
Male
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Male ≥ 50 years Symptomatic BPH International prostate symptom score (IPSS) ≥13 Prostate volume 30-80ml
Exclusion criteria
- History or high suspicion of prostate cancer
- Current urinary tract infection
- Refractory urinary retention or post-void residual (PVR) ≥250 mL
- Intravesical prostatic protrusion (IPP)\>10mm
- Prior prostate surgery
- Known or suspected allergy to nickel, titanium, or polyester/polypropylene
- Urethral stricture, meatal stenosis, bladder neck contracture
- Neurogenic bladder and/or sphincter abnormalities
Where it is running
1 location listed.
- Prince of Wales Hospital, The Chinese University of Hong Kong - Hong Kong, Hong Kong